Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.

Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships.

Soh J, Rositch AF, Koutsky L, Guthrie BL, Choi RY, Bosire RK, Gatuguta A, Smith JS, Kiarie J, Lohman-Payne B, Farquhar C.

Int J STD AIDS. 2014 Apr;25(5):315-24. doi: 10.1177/0956462413504554. Epub 2013 Sep 18.

2.

Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men.

Schwartz LM, Castle PE, Follansbee S, Borgonovo S, Fetterman B, Tokugawa D, Lorey TS, Sahasrabuddhe VV, Luhn P, Gage JC, Darragh TM, Wentzensen N.

J Infect Dis. 2013 Dec 1;208(11):1768-75. doi: 10.1093/infdis/jit374. Epub 2013 Aug 1.

3.
4.

Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART.

Piketty C, Cochand-Priollet B, Lanoy E, Si-Mohamed A, Trabelsi S, Tubiana R, Girard PM, Weiss L, Costagliola D; Valparaiso Study Group.

AIDS. 2013 Jan 28;27(3):401-6. doi: 10.1097/QAD.0b013e32835ad2cb.

PMID:
23079803
5.

[Analysis of cervical HPV infection in HIV positive Chinese women].

Zhang YX, Xiong Y, Gui XE, Rong YP, Cai HB, Ma L.

Zhonghua Fu Chan Ke Za Zhi. 2012 Mar;47(3):185-90. Chinese.

PMID:
22781069
6.

Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men.

van der Snoek EM, van der Ende ME, den Hollander JC, Schutten M, Neumann HA, van Doornum GJ.

Sex Transm Dis. 2012 Jul;39(7):495-500. doi: 10.1097/OLQ.0b013e31825aa764.

PMID:
22695316
7.

Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART.

Adler DH, Kakinami L, Modisenyane T, Tshabangu N, Mohapi L, De Bruyn G, Martinson NA, Omar T.

AIDS. 2012 Aug 24;26(13):1645-52.

8.

Assessing urine human papillomavirus polymerase chain reaction testing as a tool for screening anal HPV infection in HIV-positive MSM.

Lanoix JP, Pannier C, Borel A, El Samad Y, Robin C, Douadi Y, Woimant M, Fouche B, Lecaque C, Ganry O, Duverlie G, Sevestre H, Schmit JL.

AIDS Patient Care STDS. 2012 Apr;26(4):208-13. doi: 10.1089/apc.2011.0301. Epub 2012 Feb 9.

PMID:
22320265
9.
10.

Oral sampling and human papillomavirus genotyping in HIV-infected patients.

Steinau M, Reddy D, Sumbry A, Reznik D, Gunthel CJ, Del Rio C, Lennox JL, Unger ER, Nguyen ML.

J Oral Pathol Med. 2012 Apr;41(4):288-91. doi: 10.1111/j.1600-0714.2011.01093.x. Epub 2011 Nov 15.

PMID:
22082117
11.

Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.

Firnhaber C, Evans D, Friedman-Khalili R, Willliams S, Michelow P, Matlhagela K, Wester C, Grinsztejn B, Lockman S.

J Clin Virol. 2011 Nov;52(3):265-8. doi: 10.1016/j.jcv.2011.08.011. Epub 2011 Sep 9.

PMID:
21908233
12.

Episomal and integrated human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive men.

Alvarez J, de Pokomandy A, Rouleau D, Ghattas G, Vézina S, Coté P, Allaire G, Hadjeres R, Franco EL, Coutlée F; HIPVIRG Study Group.

AIDS. 2010 Sep 24;24(15):2355-63. doi: 10.1097/QAD.0b013e32833db9ea.

PMID:
20706109
13.

Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.

Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA 3rd, Read JS, Handelsman EL, Nowak B, Sattler CA, Saah A, Radley DR, Esser MT, Weinberg A; IMPAACT P1047 Protocol Team.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):197-204. doi: 10.1097/QAI.0b013e3181de8d26.

14.

Histologic correlates of glandular abnormalities in cervical cytology among women with human immunodeficiency virus.

Massad LS, Xie X, Darragh TM, Minkoff H, Levine AM, D'Souza G, Cajigas A, Colie C, Watts DH, Strickler HD.

Obstet Gynecol. 2009 Nov;114(5):1063-8. doi: 10.1097/AOG.0b013e3181bc6ce0.

15.

Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa.

Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, Sanne IM, Lewis DA, Williamson AL, Allan B, Williams S, Rinas A, Levin S, Smith JS.

Cancer Causes Control. 2010 Mar;21(3):433-43. doi: 10.1007/s10552-009-9475-z. Epub 2009 Dec 1.

16.

HPV types present in invasive cervical cancers of HIV-seropositive women.

Strickler HD, Palefsky JM, Burk RD.

Int J Cancer. 2008 Sep 1;123(5):1224-5. doi: 10.1002/ijc.23630. No abstract available.

PMID:
18537158
17.

Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women.

Tornesello ML, Duraturo ML, Giorgi-Rossi P, Sansone M, Piccoli R, Buonaguro L, Buonaguro FM.

J Gen Virol. 2008 Jun;89(Pt 6):1380-9. doi: 10.1099/vir.0.83553-0.

PMID:
18474553
18.

Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.

Richter KL, van Rensburg EJ, van Heerden WF, Boy SC.

J Oral Pathol Med. 2008 Oct;37(9):555-9. doi: 10.1111/j.1600-0714.2008.00670.x. Epub 2008 Mar 19.

PMID:
18355174
19.

Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women.

Harris TG, Burk RD, Xue X, Anastos K, Minkoff H, Massad LS, Young MA, Levine AM, Gange SJ, Watts DH, Palefsky JM, Strickler HD.

AIDS. 2007 Sep 12;21(14):1933-41.

PMID:
17721101
20.

Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents.

Shrestha S, Wang C, Aissani B, Wilson CM, Tang J, Kaslow RA.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1626-32.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk